CCorify Care
Corify Care is a Madrid-based medtech startup that develops ACORYS®, a non-invasive, real-time global cardiac mapping system for diagnosing and treating arrhythmias such as atrial fibrillation in under 10 minutes. Founded in 2019 as a spin-off from Hospital General Universitario Gregorio Marañón and the Universitat Politècnica de València, the company has since received FDA clearance for ACORYS® and is running U.S. clinical trials (including with Mayo Clinic) as it expands internationally.
SectorsMedtech, Cardiac Health, Digital Health, Medical Devices
Start-up MapHealthtech & Bio › Medical devices & surgical hardware
Founders
A
Andreu Climent
CEO & Founder
F
Felipe Atienza
CMO & Founder
M
María Guillem
CSO & Founder
Global models 5
A
Acutus Medical
United States · www.acutus.com ↗
Sells a real-time global cardiac mapping system (AcQMap) to hospitals and electrophysiologists for diagnosing and guiding ablation of complex arrhythmias like AF, though its mapping uses a catheter.
$300MComparable
VVolta Medical
France · www.volta-medical.com ↗
Sells an FDA-cleared AI mapping system to EP labs that finds where atrial fibrillation drivers sit, to guide ablation.
$80MComparable
VVektor Medical
United States · www.vektormedical.com ↗
Makes vMap, an FDA-cleared non-invasive system that locates arrhythmia sources from a standard 12-lead ECG, sold to hospitals for diagnosis and ablation planning.
$30MComparable
C
CardioInsight Technologies
United States
Built a non-invasive ECG-imaging vest that maps the whole heart's electrical activity in one beat to diagnose arrhythmias (acquired by Medtronic in 2015).
$30MComparable
IinHEART
France · www.inheart.fr ↗
Sells non-invasive, imaging-based digital twins of the heart to hospitals to plan and guide ablation of cardiac arrhythmias.
$15MComparable
In the same niche 72 others
See all in the Start-ups Map →
AAnaconda Biomed
Sant Cugat del Vallès
Series C (estimated) · €90.1M
IINBRAIN Neuroelectronics
Barcelona
Series B (estimated) · €84.5M
OOverture Life
Madrid
Venture Debt · €71.2M
M
Medlumics
Madrid
No stage disclosed · €57.8M
AAortyx
Barcelona
Series A · €16.9M
NNuubo
Madrid
Series B (estimated) · €16.3M
Notes: Most funded first
Investors 7
Open as list →Funding rounds 2
·1 not counted| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-12-11 | Series A (estimated) | €3M | Clave Capital |
| 2021-07-07 | Seed | €2.35M |
Clave Capital
+4 more
|
News 7
Open as list →| Published | Article |
|---|---|
| 2026-04-27 |
Corify announces studies validating 4D cardiac mapping system following US FDA clearance ↗
Cardiac Rhythm News
2026-04-27 |
| 2026-04-20 |
FDA Clears Non-invasive Cardiac Mapping Platform ↗
DAIC (Diagnostic and Interventional Cardiology)
2026-04-20 |
| 2026-01-29 |
Corify Care to Introduce First Whole-Heart Mapping Technology ↗
DAIC (Diagnostic and Interventional Cardiology)
2026-01-29 |
| 2024-12-17 |
Corify Care raises €6M to revolutionise cardiac care ↗
EIT Health
2024-12-17 |
| 2024-12-13 |
Andreu Climent (Corify Care): "Además de financiación, MONDRAGON nos da acceso a su extraordinario ecosistema" ↗
Webcapitalriesgo
2024-12-13 |
| 2024-07-29 |
EIT Health-supported Corify Care earns CE Mark ↗
EIT Health
2024-07-29 |
| 2020-05-13 |
Corify Care obtiene 1 millón de euros del CDTI para el desarrollo de ACORYS, un dispositivo médico para el tratamiento de la arritmia cardiaca ↗
El Referente
2020-05-13 |






